Mendelian vs Polygenic Inheritance in Dogs

The most important split in canine genetics is not "good genes" versus "bad genes." It is whether a trait behaves like a single-locus Mendelian trait or like a polygenic trait shaped by many loci and the environment together. That distinction determines what a DNA test can actually tell you, what breeding language is valid, and what kind of certainty is honest. Documented

What It Means

Mendelian inheritance is the classical genetics most people learn first. One locus matters. Different alleles at that locus combine in predictable ways. If the disease is autosomal recessive, two copies are needed for expression. If it is autosomal dominant, one copy is enough. Ratios like 1:2:1 or 3:1 belong to this world.

In dogs, a clear example is progressive retinal atrophy caused by a known causal mutation. For a condition like prcd-PRA, the test is answering a discrete question about one locus. A dog can be clear, carrier, or affected at that locus, and the breeding consequences follow directly from that fact. That is why Mendelian disease testing can be so powerful when the variant is truly causal and well validated in the relevant breed.

Polygenic inheritance is different. Instead of one decisive locus, many loci each contribute small effects. Those effects add together, interact with each other, and are then filtered through the environment. The visible trait is not a set of clean bins. It is a continuous distribution.

That is the world most breeder-relevant traits actually live in.

Hip dysplasia is polygenic. Elbow dysplasia is polygenic. Cancer susceptibility is polygenic and multifactorial. Temperament is polygenic. Longevity is polygenic. Even traits that look simple from a distance often become genetically messy when studied carefully at scale.

This difference explains why so much popular genetics language misfires. People want to say "the gene for temperament" or "the gene for hip dysplasia" because the single-gene story is easy to tell. But in most cases the truer phrase is "a gene associated with variation in this trait" or "a genomic region contributing some amount of risk." That is less tidy, but it is more faithful to the science.

Polygenic traits behave differently for three reasons.

First, effect sizes are usually distributed across many loci. No single marker explains most of the trait.

Second, environmental inputs matter. Growth rate, body condition, maternal effects, early stress, injury, nutrition, and management can all influence how a polygenic predisposition expresses.

Third, the output is usually quantitative rather than binary. There is not a clean border between "has it" and "does not have it" in the way carrier testing works for a single recessive disease.

That is why carrier language belongs to Mendelian disease alleles and not to most complex traits. A dog is not a "carrier for hip dysplasia" in the same sense that it can be a carrier for a recessive retinal mutation. The category itself is wrong. A dog can have a higher or lower inherited liability for a polygenic trait, but the words clear, carrier, and affected do not map cleanly onto that biology.

This also explains the role of phenotypic testing. When a trait is polygenic and expressed through anatomy or physiology, the phenotype often remains the more clinically useful measurement. Hip evaluation is the obvious example. A DNA-based risk score might eventually contribute useful probabilistic information, but it does not replace looking at the joint itself. Radiographic or imaging-based evaluation measures the trait's actual bodily expression. A polygenic DNA score estimates liability. Those are not the same thing.

The family-facing rule is simple: if someone claims to have DNA-tested a dog "for hip dysplasia" as though that settles the matter, the statement is oversimplified. At best, the test is reporting a risk model built from associated loci. It is not diagnosing the dog's hips.

The same caution applies to cancer and behavior. It is fair to study genomic regions associated with hemangiosarcoma susceptibility, fearfulness, sociability, or working traits. It is not fair to market a small set of markers as if they can read one puppy's destiny.

What This Cannot Predict

Knowing that a trait is Mendelian does not automatically tell you everything important about it. Penetrance, age of onset, and mutation heterogeneity still matter. A dog can test clear for one mutation and still not be "cleared" against every possible disease in that phenotype family.

Knowing that a trait is polygenic also does not mean genetics are irrelevant. Polygenic does not mean random. It means distributed, probabilistic, and harder to summarize honestly.

The main thing this distinction cannot justify is false certainty. Single-gene thinking should not be forced onto complex traits because it makes breeder marketing simpler. And the existence of polygenic complexity should not be used to imply that nothing genetic can be known at all. The reality is in the middle: some loci can be known with high confidence, many important traits remain polygenic, and the interpretive language has to match the architecture.

Why It Matters for Your Dog

This page matters because families hear genetic claims before they have the vocabulary to sort them.

If a breeder says, "We test for PRA," that may be a valid single-locus statement depending on the mutation and the breed context. If someone says, "We tested for hips by DNA," the interpretation has to be different. One claim may be close to binary. The other is necessarily probabilistic.

That difference protects buyers from two common mistakes:

• assuming every DNA result carries the same level of certainty
• assuming a complex trait has been fully explained because one marker or one panel mentioned it

For breeders, the stakes are even higher. Mendelian disease alleles can often be managed precisely through carrier-to-clear strategies without losing good dogs from the gene pool. Polygenic traits require slower, population-level progress through phenotyping, careful mate selection, long-term record keeping, and humility about what cannot yet be measured directly.

For JB, this matters because the breeding program is selecting for a dog that can actually live the philosophy. Temperament is part of that target, but temperament is not a single switch. It is a polygenic and developmental trait. That means good breeding helps shift the odds, while raising still matters enormously.

The Evidence

Sources

• Source_JB--Golden_Retriever_Inherited_Disease_Genetics.md.
• Source_JB--Canine_Genetic_Diversity_and_Population_Health.md.
• Canine complex-trait and quantitative-genetics literature summarized in the JB source layer.